Learning Objectives:
1. Understand evolving experimental applications of gene therapy for neurodegenerative disease.
2. Understand the role of focused ultrasound lesioning for treatment of movement disorders.
3. Understand the mechanism and role of focused ultrasound blood brain barrier disruption for treatment of neurodegenerative disorders.
Session date:
08/14/2019 - 8:30am to 9:30am CDT
Location:
UCMC
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Michael G. Kaplitt, MD, PhD